Cite
HARVARD Citation
Montgomery, S. et al. (2017). A discrete event simulation to model the cost-utility of fingolimod and natalizumab in rapidly evolving severe relapsing-remitting multiple sclerosis in the UK. Journal of medical economics. pp. 474-482. [Online].